Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostate Cancer Metastatic × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Fallopian Tube Neoplasms 8 Ovarian Neoplasms 7 Prostatic Neoplasms 6 Endometrial Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Breast Neoplasms 5 Recurrence 3 Pancreatic Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Pathologic Complete Response 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration Resistant Prostate Cancer 1 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1 Lymphoma, Non-Hodgkin 1

Interventions

enzalutamide 3 cabazitaxel 3 Prednisone 3 Docetaxel 2 Abiraterone Acetate 2 rucaparib 1 Zuclomiphene 1 XRP6258 1 LY3023414 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03413995 2024-10-16

TRIUMPH

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

12 enrolled 11 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡